Rosuvastatin Calcium for Hyperlipidemia- Uses, Dosage, and Side Effects

What Is Rosuvastatin Calcium Used For?

Rosuvastatin calcium is a commonly prescribed medication to lower cholesterol and triglyceride levels in the blood. These conditions together are known as hyperlipidemia. When cholesterol levels are high, especially “bad” cholesterol, it raises the risk of heart problems and stroke by increasing fat deposits in the blood vessels. Rosuvastatin helps control these lipid levels and protects heart health by blocking a specific enzyme in the liver that helps produce cholesterol.

Is Rosuvastatin Calcium US FDA-Approved?

Rosuvastatin calcium was approved by the United States Food and Drug Administration (USFDA) on 13th August 2003 for the treatment of elevated cholesterol and related lipid disorders.

Drug Group

Rosuvastatin calcium comes under the category known as statins. Statins are taken to lower cholesterol levels. They work by blocking an enzyme in the liver called HMG-CoA (Hydroxy-3-Methylglutaryl-Coenzyme A) reductase, which plays an important role in making cholesterol.

When this enzyme is blocked:

• The liver produces less cholesterol.

• Levels of LDL (bad cholesterol) and triglycerides go down.

• Levels of HDL (good cholesterol) may increase slightly.

This overall effect helps reduce the risk of heart attacks and strokes.

Available Dosages

Rosuvastatin calcium is available in tablet form in the following strengths:

• 5 mg.

• 10 mg.

• 20 mg.

• 40 mg.

The exact dose will be determined by the doctor based on your cholesterol levels, age, and other health conditions.

For Patients

How Does Rosuvastatin Calcium Help Manage Hyperlipidemia?

Hyperlipidemia means having higher-than-normal levels of fats (lipids) in the blood. These fats include cholesterol and triglycerides.

The condition may be:

• Primary – due to genetic or family history.

• Secondary – caused by lifestyle habits or other medical conditions.

High lipid levels increase the risk of serious heart problems, including heart disease and stroke. Treatment usually includes lifestyle changes along with medications when needed.

Rosuvastatin calcium helps manage hyperlipidemia as part of a complete treatment plan that includes the following:

• Healthy Diet: Eating a heart-healthy diet is very important. This includes more fruits, vegetables, whole grains, nuts, and foods that contain omega-3 fatty acids, while reducing fatty foods, fried items, processed foods, and sugary carbohydrates.

• Regular Exercise: Being active, such as brisk walking, for about 30 minutes on most days helps keep cholesterol and the heart healthy.

• Weight Control: Keeping a healthy body weight helps lower cholesterol and protects the heart.

• Stop Smoking: Quitting smoking improves heart health and helps increase good (HDL) cholesterol.

• Limit Alcohol: Drinking too much alcohol can increase fat levels in the blood, so it’s best to limit or avoid it.

• Medicines: Statins like Rosuvastatin are the first-choice medicines for lowering LDL cholesterol. Other medicines may be added if needed, such as Fibrates, Niacin, Ezetimibe, PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) inhibitors, or omega-3 fatty acid supplements.

• Regular Monitoring: Periodic blood tests and follow-up with your doctor are essential to check cholesterol levels and ensure the treatment is working well.

Treatment should always be individualized, taking into account the patient’s overall health, risk factors, and any other medical conditions, to achieve the best results.

How Does Rosuvastatin Calcium Work?

• Rosuvastatin calcium works by blocking HMG-CoA reductase, an enzyme the liver uses to make cholesterol.

• By stopping this enzyme, the liver produces less cholesterol overall.

• The liver then removes more LDL (bad cholesterol) from the blood and breaks it down.

• This process leads to a reduction in LDL cholesterol levels.

• At the same time, it helps increase HDL (good cholesterol).

• Rosuvastatin also helps lower triglyceride levels in the blood.

• These combined effects reduce fatty plaque buildup in arteries.

• As a result, it lowers the risk of heart attacks, strokes, and other cardiovascular diseases.

What Are the Clinical Uses of Rosuvastatin Calcium in High Cholesterol?

Rosuvastatin calcium is a medicine used to control high cholesterol. It improves blood fat levels and helps keep the heart and blood vessels healthy.

• Lowers Bad Cholesterol (LDL): It reduces LDL cholesterol, which can contribute to the formation of blood clots, leading to heart problems.

• Raises Good Cholesterol (HDL): It slightly increases HDL cholesterol, which helps remove extra cholesterol from the blood.

• Lowers Triglycerides: It reduces triglyceride levels, another type of fat that increases heart disease risk.

• Prevents Heart Problems: By improving cholesterol levels, it lowers the risk of heart attack and stroke.

• Reduces Blood Vessel Inflammation: It reduces inflammation and stabilizes fatty plaques.

• Slows Artery Blockage: It slows the buildup of fatty deposits in arteries and helps keep them healthier.

What Are the Side Effects of Using Rosuvastatin Calcium?

• Headache.

• Abdominal discomfort.

• Constipation.

• Nausea.

• Dizziness.

• Increased blood sugar levels.

• Liver problems like fatty liver disease and hepatitis.

• Allergic reactions, including rash or itching.

For Doctors:

Dosage and Administration:

• The dose of Rosuvastatin calcium is determined based on the patient’s condition, LDL cholesterol level, and risk of heart disease.

• In adults, the usual dose is 5-40 mg, taken once daily by mouth.

• For children under eight years of age, the recommended dose is 5 to 10 mg once daily.

• For patients 10 years and older, the dose generally ranges from 5 to 20 mg once daily.

• Pediatric patients with homozygous familial hypercholesterolemia are usually prescribed 20 mg once daily.

Indications:

The HMG Co-A reductase inhibitor (statin) Rosuvastatin calcium is recommended for the following purposes:

To reduce the risk of stroke, myocardial infarction (heart attack), and arterial revascularization procedures in adults without established coronary heart disease who are at increased risk of cardiovascular (CV) disease due to age, hs-CRP (high-sensitivity C-reactive protein) greater than 2 mg/L, and at least one additional CV (cardiovascular) risk factor.

1. As a supplement to diet in persons with primary hyperlipidemia to lower LDL-C.

2. As a supplement to diet in adults with heterozygous familial hypercholesterolemia (HeFH) and in pediatric patients eight years of age and older to lower low-density lipoprotein cholesterol (LDL-C) and prevent the progression of atherosclerosis.

3. In adults or pediatric patients aged seven years or older with homozygous familial hypercholesterolemia (HoFH), as an adjuvant to existing LDL-C-lowering medicines or in isolation if such treatments are not available.

4. In adults with primary dysbetalipoproteinemia, it is a dietary supplement for the treatment of hypercholesterolemia.

Contraindications:

• It should not be used in people with severe liver disease, like acute liver failure or advanced liver cirrhosis.

• It should be avoided if the person is allergic to rosuvastatin calcium or any of the medicine's ingredients.

Warning and Precautions:

Myopathy and Rhabdomyolysis:

• Myopathy and rhabdomyolysis are known as muscle-related risks with Rosuvastatin calcium.

• Risk factors include age over 65 years, untreated hypothyroidism, kidney disease, high doses, and use of certain interacting medicines.

• Muscle problems may occur more frequently in Asian patients.

• Rosuvastatin calcium should be stopped immediately if muscle pain, weakness, or tenderness is suspected, or if creatine kinase (CK) levels are markedly elevated.

• The medicine should be temporarily discontinued in patients with serious acute illnesses that increase the risk of kidney failure due to muscle breakdown.

• Patients should be informed before starting or increasing the dose about the risk of muscle-related side effects.

• Patients must report unexplained muscle pain, weakness, or tenderness promptly, especially if accompanied by fever or general discomfort.

• Rare cases of immune-mediated necrotizing myopathy (IMNM), an autoimmune muscle condition, have been reported with statin use.

• Rosuvastatin calcium should be discontinued if IMNM is suspected.

Hepatic Dysfunction:

Rosuvastatin calcium has been shown to increase serum transaminase levels, which indicate liver stress or damage. Hepatic failure, both deadly and non-fatal, has been reported rarely. Before starting treatment and whenever clinically indicated, consider having liver enzyme tests.

In the event of a severe hepatic injury manifesting clinical signs, hyperbilirubinemia, or jaundice, stop taking Rosuvastatin calcium immediately.

What Are the Adverse Reactions to Rosuvastatin Calcium?

• Unexplained muscle pain.

• Tenderness.

• Weakness.

• Cramps.

What Are the Pharmacological Aspects of Rosuvastatin Calcium?

• Mechanism of Action: HMG-CoA reductase, the rate-limiting enzyme that changes 3-hydroxy-3-methylglutaryl coenzyme A into mevalonate, a precursor of cholesterol, is inhibited by Rosuvastatin calcium.

• Pharmacodynamics: Rosuvastatin calcium inhibits HMG-CoA reductase, which speeds up the development of LDL receptors and the liver's absorption of LDL-C, resulting in a drop in plasma LDL-C and total cholesterol. Persistent hepatic suppression of cholesterol production reduces very low-density lipoprotein (VLDL) levels. Rosuvastatin calcium typically achieves and maintains its maximum LDL-C decrease within four weeks.

• Pharmacokinetics: Peak plasma concentrations of Rosuvastatin calcium were attained three to five hours after oral dosage in human clinical pharmacology investigations. The increases in Cmax and AUC were roughly proportional to the calcium-containing Rosuvastatin dosage. Rosuvastatin calcium has an absolute bioavailability of 17-20%. After taking Rosuvastatin calcium in the morning or the evening, the AUC is the same.

Use in Specific Populations:

• Pregnancy: It is not advised to take Rosuvastatin calcium while pregnant because it may harm the developing baby.

• Lactation: There is limited published evidence that human milk contains Rosuvastatin calcium, based on case reports. Rosuvastatin passes into human breast milk only when the mother is actively taking the medication. Information regarding the drug's effects on nursing infants or their ability to produce milk is currently unavailable. Statins, such as Rosuvastatin calcium, inhibit cholesterol synthesis and may also inhibit the synthesis of other physiologically active molecules derived from cholesterol, which could be harmful to a newborn who is breastfed.

• Pediatrics: When used in conjunction with diet to lower LDL-C, Rosuvastatin calcium is safe and effective in children with HeFH (heterozygous familial hypercholesterolemia) aged 8 years and older.

• Geriatrics: 698 (6.8 percent) and 3159 (31 percent) of the total number of patients receiving Rosuvastatin calcium treatment in clinical trials were 75 years of age or older. No general changes in safety or effectiveness were found between older and younger subjects.

• Acute Liver Failure: Patients with decompensated cirrhosis or acute liver failure should not use Rosuvastatin calcium. Exposure to Rosuvastatin calcium is known to increase chronic alcoholic liver disease. Individuals with a history of liver illness, heavy alcohol consumption, or both may be more vulnerable to hepatic damage.

Clinical Studies:

• Cardiovascular diseases remain a leading cause of illness and death in Western countries.

• Statins have greatly improved the treatment of abnormal lipid levels in both primary and secondary prevention of heart disease.

• Rosuvastatin is a newer statin known for its strong LDL-cholesterol-lowering effect and a favorable safety profile.

• Large-scale data on its impact on mortality and morbidity are still being studied through the GALAXY clinical trial, which involves more than 20,000 patients in 30 countries.

• A key advantage of Rosuvastatin is its ability to produce substantial LDL reduction at a low starting dose of 10 mg, gradually reducing the need for frequent dose adjustments.

• At a 10 mg dose, Rosuvastatin lowers LDL cholesterol by approximately 47 to 48%.

• This reduction is greater than that seen with Atorvastatin 10 mg, Simvastatin 20 mg, and Pravastatin 20 mg.

• Studies show that higher doses of Rosuvastatin lead to even greater reductions in LDL cholesterol.